企业宣传图
holter > English > News > Company news >

Remote cardiac monitoring technology received the invention patent granted in Korean

Published time:2015-01-25 | viewed:

Today, Korean invention patent office (KIPO) releases an announcement that our invention patent “A MOBILE NETWORK TERMINAL DEVICE AND METHOD OF ELECTROPHYSIOLOGICAL DATA AND PATHOLOGICAL IMAGE MONITORING “has finished the examination as to substance and been finally granted in KIPO. So far, our company has obtained the authorization of patent in America, Australia and Taiwan, which makes us win attention of the same industry in the international market.

The invention patent “A MOBILE NETWORK TERMINAL DEVICE AND METHOD OF ELECTROPHYSIOLOGICAL DATA AND PATHOLOGICAL IMAGE MONITORING “plays an important role in global wearable mobile medical technologies. It involves in the world's first mobile medical terminal with direct access to mobile network, with no need to connect with phone or network devices to forward data. Furthermore, the mobile medical terminal greatly increases speed of computing electrophysiological data, realizes adaptive and real-time analysis, and accurately captures high-risk data and gives these data to clinicians for decision-making. Meanwhile, the patent technology could be used to remotely monitor pathological image, which broadens clinical value of remote medical technology. Compared with dual-system architecture technology, this patent technology increases reliability, reduces manufacturing costs, facilitates long-term use and drives the development of international remote monitoring technology.

Over the last decade our company closely works with Chinese hospitals and experts for cardiovascular disease. They endeavor to research remote mobile technology suitable for clinical use and promote the technology to benefit human beings and reduce risks of heart diseases.